Ang-2-VEGF-A crossmab, a novel bispecific human IgG1 antibody blocking VEGF-A and Ang-2 functions simultaneously, mediates potent antitumor, antiangiogenic, and antimetastatic efficacy - Kienast, Yvonne; Augustin, Hellmut (Clinical cancer research, 2013)
Gesehen am: 12.03.2014